Intel Capital first sold half its stake in Intrasoft last month and has now exited the remaining 5.3% stake.

OpenText is set to acquire Recommind for $163m, giving an exit to SAP-backed Sapphire Ventures.

The initial public offering on Aim will provide an exit to shareholders including Novartis, which gave Mereo access to three of its clinical stage therapies last year.

The RFID technology developer, backed by investors such as UPS and Intel, has filed for a $60m IPO after previously withdrawing a $100m offering in 2012.

Santen-backed Clearside Biomedical, which had raised some $48m in funding, is offering 7.2 million shares on Nasdaq priced at $7 each.

The personalised healthcare subsidiary of NantWorks, backed by Celgene, Blackberry and Allscripts, has priced its initial public offering at $14 a share.

BrightPoint, backed by EMC and originally known as Vorstack, is set to be acquired in all-cash transaction by ServiceNow.